Since its inception in 1981, AST has witnessed and contributed to the rapid growth of transplantation performances in Asia.
AST focuses on capacity enhancement especially in deceased organ transplantation and translational research based on a registry that we all assemble together and it will be valuable scientific data for further research. AST has and will continue to propagate the ethical practices in transplantation by advocating the DICG.
AST acknowledges the contribution that Asian women have made throughout the years and will support them by providing the Women In Transplantation initiative.
AST will endeavor to provide growth of transplantation in the Continent of Asia through scientific knowledge, clinical practice and continuing education with emphasis on ethical practice of transplantation.
The Argentinian Society of Transplantation is a Civil Association that brings together doctors, biochemists, biologists, psychologists with academic and scientific interests in organ transplants.
It is currently made up of members trained in different specialties, since in Argentina heart, liver, lung, kidney, bone, bone marrow, pancreatic, corneal, skin and tissue transplants are performed.
Created in 1982, the Society was re-founded in 1994 in order to enable the broad participation of all Argentine professionals.
Ba?kent University was founded in 1993 as one of the first foundation universities of Turkey. The founder and president is Prof. Dr. Mehmet Haberal who also made the first successful transplantation surgery in Turkey (1975) and is a well-known person in the international transplantation community.
Ba?kent University has a broad spectrum of faculties in all the branches of science like medicine, engineering, administrative sciences, social and political sciences and law. The University has 12 hospitals and dialysis centers all over the country and works therefore in a medical network. Besides all medical departments, our scientific efforts are especially concentrated in the fields of liver, kidney, heart, cornea and bone marrow transplantation, HLA typing and immunogenetics and burn care.
Reimagine the Future of Organ Transport and Preservation
Bridge to Life is known around the world for our unwavering commitment to quality and service. And we are committed to this and more in Latin America. We’re focusing beyond simple product needs to be a true partner to the transplant community – constantly looking for new ways to increase the quality and quantity of donor organs to save more lives. Because for us, it’s not just about solutions, but the entire journey.
CareDx, Inc., based out of Brisbane, California, is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.
Las Lupas Perioptix son lupas premium fabricadas con dos objetivos.
El primero es tener una magnificación, iluminación y calidad óptima.
El segundo es proteger la postura de los profesionales al momento de estar largas jornadas en procedimientos quirúrgicos mejorando significativamente la postura de trabajo evitando encorvarse para obtener una buena visión del campo quirúrgico reduciendo la fatiga y extiendiendo la longevidad de la profesión.
Las Lupas PeriOptix se fabrican especialmente para usted como si fuera un traje a medida en nuestro Laboratorio de California.
La fabricación se realiza en base a la ubicación de sus pupilas en su rostro, las distancia que separa a sus ojos del campo operatorio y su prescripción oftalmológica (en el caso de usar lentes de cerca/media distancia).
Una lupa ultra liviana de sólo 56gr le permite realizar su trabajo sin generar stress en la musculatura de los ojos y cabeza, preservando su visión y eliminando dolores de cabeza. Las lupas mantendrán su espalda derecha evitando que trabaje en posiciones forzadas que favorecen al desarrollo de deformaciones musculoesqueléticas y consecuentes dolores de espalda y cuello.
DONASUR is a region-wide information technology project for the collection and publication of official information on organ donation and transplantation. It allows information to be compared between countries, as well as the standardization of criteria and languages, and ensures safe, transparent processes.
DONASUR gathers individual data from donors and recipients (it is a Register of individual concluded events not summarized). The countries directly update the information by means of tools and automatize and make the task easier, besides it is backed up by local systems. The model allows traceability, biomonitoring and ensures information reliability. On the other hand it enables access in due course, making comparative and historical analysis of information more efficient and fostering the consolidation of language in terms of donation and transplant.
Dr. Franz Köhler Chemie GmbH is a family-owned and managed company with long history and experience since 1959, including a high sophisticated state-of-the-art GMP-production (capacity more than 6000 litres/day), own certified API production, own research and development center, numerous interdisciplinary joint projects with internationally renowned universities and hospitals, and a worldwide partners and distribution network. Our major brand, CUSTODIOL® (the original HTK Bretschneider® solution), is a ready-to-use intracellular solution used by transplant and cardiac surgery centers in more than 90 countries.
DTI Foundation is an international non-profit organization committed to raise organ and tissue donation by providing training, counselling and support to international entities and to the public and private health sector in the creation, development and strengthening of networks, programs and services concerning donation and transplantation of organs, tissues and human cells.
The main goals of the Foundation include:
• To increase opportunities for access to organ and tissue transplantation.
• To promote the application of new technologies in the field of healthcare.
• To foster development and cooperation among peoples in the field of health and in the field of related teaching and research.
Transplant Procurement Management (TPM®) is its educational program that since 1991 has trained over 18.000 participants from 102 countries in the best practices of organ and tissue donation and transplantation. TPM training programs are designed to adapt the contents to the specific needs of the diverse countries’ situation.
E3 CORTEX, french company, family owned, created in 1983, specialized in the design and manufacture of approved packaging for the transport of controlled and/or sensitive biological substances, primarily organs intended for transplantation.
Thanks to the VITALPACK EVO, Class IIa Medical Device that complies with the requirements of Directive 93/42 EEC, designed for the transport of organs in cold ischemia, and its associated Medical Device, the BIOTAINER 2.8L Kit (sterile).
Its technology guarantees a stable and homogeneous transport temperature, using eutectic plates as a cooling source (dry cold, eliminates the risk of contamination through crushed ice), ensuring a constant temperature of the organ.
E3 Cortex has chosen to go for a French based production, 95% of raw material purchases are made in France and 100% in Europe, while favouring the choice of eco-responsible suppliers.
Gador is an Argentine pharmaceutical company driven by a community of professionals and specialists committed to providing people access to medicines of excellence, manufactured and distributed with the latest technology available and following the highest international standards to reach Argentina and the world.
In constant growth since its foundation in 1940, today its products for primary health care and special products are present throughout the national territory and in more than 40 countries, either through its own subsidiaries, leading distributors, or by technology transfer to strategic partners.
With over 1,200 employees through its headquarters and subsidiaries in Chile, Uruguay, Peru, Colombia, Paraguay, Brazil and Ecuador, Gador has built strategic alliances with several international companies partnering to market their licensed products in Argentina and in LATAM.
Glycorex Transplantation is an internationally well-established medical device company and in the forefront of ABO-incompatible transplantation technologies.
Our Glycosorb®-ABO are medical devices that bio-specifically bind anti-A/B antibodies, enabling ABO-incompatible transplantation and transfusion.
The products have high capacity to reduce anti-A/B antibodies with no unspecific binding of other plasma components. The treatment is well tolerated by children and adults with excellent short- and long-term results documented in 60+ scientific articles since the first kidney transplantation using Glycosorb®-ABO took place in 2001.
Today, Glycorex Transplantation have participated in more than 5.000 transplantations in 28 countries and Glycosorb®-ABO is increasingly used within ABO-incompatible kidney, liver, heart, and stem cell transplantations world-wide.
The National Single Central Institute of Ablation and Implant Coordinator (INCUCAI) is the body that promotes, standardizes, coordinates and supervises the donation and transplantation activities of organs, tissues and cells in Argentina. It acts in the Argentine provinces together with 24 jurisdictional organisms of ablation and implantation in order to provide the population with transparent and equitable access to transplantation.
INCUCAI is a decentralized entity under the Secretariat of Policies, Regulation and Institutes of the Ministry of Health (Argentina). Its actions are aimed at effectively enforcing the Organ Transplant Law, regulations that establish the lines of its operation, to meet the demand of patients waiting for a transplant.
The mission of INCUCAI is to promote, regulate and coordinate activities related to the procurement and transplantation of organs, tissues and cells in Argentina, guaranteeing transparency, equity and quality.
CUCAIBA, the Organ Procurement and Transplant Organization in Buenos Aires Province, Argentina, is the Center dependent on the Ministry of Health, created by provincial law 10.586, responsible for carrying out the Provincial Program for Organ Transplantation throughout the jurisdiction, whose main objectives are to promote the procurement of organs and tissues, develop transplant services in public hospitals, manage authorizations for transplant institutions and teams in public and private establishments throughout the province and guarantee access to transplants for all Buenos Aires residents.
At Novartis, we are reimagining medicine. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
One Lambda, Inc. has been the global leader in transplant diagnostics for over thirty years. As part of Thermo Fisher Scientific’s Transplant Diagnostics Division, the company offers a portfolio of integrated Transplant Management Solutions that are used by transplant centers for the detection of donor-specific antibodies with LABScreen™ Single Antigen Beads and biopsy assessment with MMDx (the Molecular Microscope® Diagnostic System).
The driving force behind our continuous product development, educational programs, and excellent customer service is our core mission of improving the lives of transplant patients. This, along with our commitment to partnering with clinical researchers around the world, has enabled us to set the standard of care in the transplant diagnostics community. Visit www.onelambda.com to discover how we can help you manage your patients with greater confidence.
Organ Recovery Systems is committed to designing and delivering exceptional clinical tools and services to preserve and protect donor organs. We support global transplant programs with our proprietary LifePort® Kidney Transporter and LifePort Liver Transporter, along with organ preservation solutions SPS-1® (UW solution), KPS-1®, and Vasosol®.
In addition to providing innovative preservation products, Organ Recovery Systems provides support to our clients via the LifePort mobile app, 24/7 Perfusion Helpline, in-person and virtual Instructor-Led Training, and a Client Community, where LifePort users can watch training videos and complete online courses.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.
Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.
We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.
R&D Focus Areas: Vaccines, Immunology & Inflammation, Oncology, Rare Blood Disorders, Rare Diseases, Neurology, among others.
Sanofi Present in around 100 countries, around 100 000 people, Close to 70 manufacturing sites, Close to 20 R&D sites.
Celebrating 100 Years of Excellence and Our Journey Continues!
The highest quality surgical instruments have been designed and manufactured by the Scanlan Family since 1921.
Experience the Scanlan difference at exhibit #5.
The Latin American and Caribbean Transplant Society originated from the merger of the two Transplant Societies that existed in Latin America until 1999: The Latin American Transplant Society, established in 1980, and the Pan American Dialysis and Transplant Society founded in 1987.
The Society was created with the primary mission of unifying the Latin American and Caribbean region for educational, research, and practical purposes, bringing together all professionals who practice any activity related to organ transplantation and contributing to the improvement of research and practice in organ transplantation.
Takeda is a patient-focused, global biopharmaceutical company. We continue to seek new possibilities in transplantation, including potential treatment options to help address the unmet medical needs of transplant recipients with cytomegalovirus (CMV) infection. More information can be found on www.clinicaltrials.takeda.com.
The mission of The Transplantation Society is to provide global leadership in the practice of human transplantation. The responsibility of The Transplantation Society is to establish guidelines of clinical practice, advance programs of education, and to promote ethical standards for clinical care and scientific investigation.
La Fundación Universitaria Dr. René G. Favaloro es una institución pública, de gestión privada y sin fines de lucro destinada a la formación de profesionales en áreas de salud, ciencia y tecnología.
Con la convicción de que sin investigación no es posible el progreso de los conocimientos, su fundador desarrolló en 1992 un Instituto de Investigación, piedra fundacional de lo que en 1998 se constituyera como la Universidad Favaloro (UF).
El objetivo de nuestros planes de estudio y programas académicos es formar un profesional con:
VectivBio is a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need. VectivBio’s product candidate, apraglutide*, is a next-generation, long-acting glucagon-like peptide-2 (GLP-2) analog being studied in the global Phase 3 STARS trial for the treatment of short bowel syndrome with intestinal failure (SBS-IF).
*Apraglutide is an investigational agent and is not approved in any region.
Established in 1978, the World Transplant Games Federation is a worldwide organisation with representation from over 60 countries that celebrates successful transplantation and the gift of life through unique and inspiring events: The Summer and Winter World Transplant Games.
We also create additional programs to encourage transplant recipients at all levels and stages of their recovery to strive towards full rehabilitation through exercise, camaraderie, mental wellbeing, and healthy living.
Our principal aim is to raise public awareness of the importance and benefits of organ donation by demonstrating that health and fitness can be achieved post-transplant. Our athletes are our ambassadors for organ donation and transplantation and give hope to people on transplant waiting lists.
Talaris Therapeutics is a late-clinical stage cell therapy company that is developing an innovative method of allogeneic stem cell transplantation that we believe has the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe non-malignant blood, immune and metabolic disorders. In the organ transplant setting, which is our initial focus, we believe that our proprietary therapeutic approach could prevent organ rejection without the consequences associated with the use of chronic immunosuppression.